Primary lymphoma of the bladder is a rare entity, and when found in such an unusual location it frequently is difficult to distinguish between a lymphoma and an undifferentiated carcinoma. Immunohistochemical staining techniques have been used to identify tumor cell origins when the tissue type or a primary site of involvement is unknown. We report a case of primary lymphoma (nonHodgkin's type) of the bladder and the use of immunohistochemical staining to distinguish definitively tissue type and then specific immunotype.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0022-5347(17)45216-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prognostic Factors for Survival in Adults With Burkitt Lymphoma: A Systematic Review.
Cancer Med
February 2025
ERN-EuroBloodNet, Hôpital St Louis/Université Paris 7, Paris, France.
Introduction: Burkitt lymphoma (BL) is a rare and aggressive subtype of non-Hodgkin's lymphoma. Several studies have identified prognostic factors (PFs) for disease progression and mortality among adults with BL. However, there is no consensus on risk stratification based on PFs.
View Article and Find Full Text PDFIntroduction: Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive lymphoma with a poor prognosis. AITL is associated with Epstein-Barr virus (EBV)-positive B cells in most cases, suggesting a possible role for the virus in the pathobiology of AITL. Cell lines from AITL patients do not exist and models of human AITL are needed.
View Article and Find Full Text PDFA Rare Head and Neck Tumor: Making Simple Things Complicated.
Cureus
December 2024
Pathology, Sir Ganga Ram Hospital, New Delhi, IND.
Primary cutaneous anaplastic large cell lymphoma (ALCL) is a very uncommon type of CD30-positive T-cell lymphoma, and it very rarely affects the forehead. We report the case of a 68-year-old male presenting with an ulcerative lesion on the right forehead, initially suspected as a benign condition. Fine needle aspiration suggested a lymphoproliferative disorder, with biopsy and immunohistochemistry confirming primary cutaneous ALCL (CD30-positive, anaplastic lymphoma kinase [ALK]-negative).
View Article and Find Full Text PDFIndolent lymphoma: addressing the needs of survivors.
Leuk Lymphoma
January 2025
School of Clinical Sciences at Monash Health, Lymphoma Research Group, Monash University, Clayton, Australia.
Over the past two decades, there has been a continuous improvement in outcome for patients with indolent lymphoma (iNHL) resulting in a gradual accumulation of survivors. While life expectancy in the current era approaches that of the lymphoma-free population, patients continue to experience lifelong complications of the disease and its treatment affecting general health, emotional, psychological and social wellbeing, relationships, employment, finances, and fitness. Contemporary care models while suited to the management of lymphoma are often lacking when it comes to identification and management of these additional needs.
View Article and Find Full Text PDFA 64-year-old man was admitted to the hospital with low back pain. Enhanced CT imaging revealed an isolated retroperitoneal mass. Since primary retroperitoneal lymphoma could not be ruled out, the patient was enrolled in our clinical trial of 68Ga-pentixafor PET/CT.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!